ArchiMed Mergers and Acquisitions Summary

Private Equity Firm Profile

In the last 3 years, ArchiMed has acquired 9 companies. It has also invested in 2 others.

ArchiMed’s most common sectors for investment aremedical products (30%) and life science (25%) . The Firm’s most common investment types include buyout (lbo, mbo, mbi) (65%) and growth capital (15%). In total, ArchiMed has invested in 3 US states and 9 different countries. Its largest (disclosed) acquisition occurred in 2019 when it acquired Bomi Italia for $79M.

In the last 3 years, ArchiMed has exited 1 company. The Firm’s most common exit type is secondary buyout (100%).

Join Mergr to view ArchiMed’s full profile and discover more middle-market private equity firms just like it.

M&A Summary

  • M&A Total Activity21
    • M&A Buy Activity20
    • M&A Sell Activity1
  • Total Sectors Invested 7
  • Total Countries Invested 9
  • M&A Buy/Sell Connections 1
  • M&A Advisors 1

ArchiMed

2, place de Francfort,
Lyon, 69003
France
+33 4 81 11 35 33
www.archimed-group.eu
contact@archimed-group.eu

ArchiMed is a specialist French private equity firm focused on buyouts of and growth capital investments in European healthcare-oriented companies. The Firm looks to invest €5 to €300 million per transaction and specifically targets companies in the public health, care and wellness, biotech, and medical technology segments of the healthcare industry. ArchiMed was formed in 2014 and is headquartered in Lyon.


Investment Criteria

Sectors of Interest: Consumer Services, Healthcare Services, Life Science, Medical Products, Test/Measurement Equipment

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Recapitalization, Stake Purchase

Geographic Preferences: United Kingdom, Western Europe, Eastern Europe, Scandinavia

Transaction Criteria Min Max
Target Revenue 5 100
Target EBITDA - -
Investment Size 5 300
Enterprise Value - -
values in millions of EUR

M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (2.2/yr) # 9 - 3 3 2 3 20
vol $14M $79M $92M
Sell (0.2/yr) # - - - 1 - - 1
  21

Most Recent M&A

Company Date Value Type
Xpress Biologics SA 2021-10-05 - Growth Capital
Milmort, Belgium · www.xpress-biologics.com
Stragen Pharma SA 2021-06-24 - Buyout (LBO, MBO, MBI)
Geneva, Switzerland · www.stragen.ch
ZytoMax GmbH 2021-01-12 - Buyout (LBO, MBO, MBI)
Dusseldorf, Germany
North American Science Associates, Inc. (NAMSA) 2020-09-01 - Buyout (LBO, MBO, MBI)
Northwood, Ohio · www.namsa.com
ActiGraph LLC 2020-05-18 - Buyout (LBO, MBO, MBI)
Pensacola, Florida · www.actigraphcorp.com
Direct Healthcare Group 2019-12-09 - Secondary Buyout
Caerphilly, United Kingdom · www.directhealthcaregroup.com
Primo Group S.p.A. 2019-10-15 - Secondary Buyout
Torino, Italy · www.centridentisticiprimo.it
Eurolyser Diagnostica GmbH 2019-07-09 - Buyout (LBO, MBO, MBI)
Salzburg, Austria · www.eurolyser.com
Bomi Italia S.p.A. 2019-03-01 79M EUR Going Private
Vaprio d’Adda, Italy · www.bomigroup.com
Clean Cells 2018-11-22 - Secondary Buyout
Bouffere, France · www.clean-cells.com
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
Direct Healthcare Group 2019-12-09 Handicare AS - Patient Handling Division 2020-04-09 3
Caerphilly, United Kingdom · www.directhealthcaregroup.com Kista, Sweden

M&A by Sector

Sector Current # Value All-time # Value
Medical Products 6 (33%) - 6 (30%) -
Life Science 5 (28%) - 5 (25%) -
Healthcare Services 2 (11%) 79M (100%) 4 (20%) 92M (100%)
Consumer Products 2 (11%) - 2 (10%) -
Business Services 1 (6%) - 1 (5%) -
Technology Hardware 1 (6%) - 1 (5%) -
Test/Measurement Equipment 1 (6%) - 1 (5%) -
Total 18 $79M 20 $92M

Acquisitions By Geo

State/Country Current # Value All-time # Value
France 6 (33%) - 6 (30%) -
United Kingdom 3 (17%) - 3 (15%) -
Italy 2 (11%) 79M (100%) 3 (15%) 79M (85%)
United States 2 (11%) - 3 (15%) 14M (15%)
  Ohio 1 (6%) - 1 (5%) -
  Florida 1 (6%) - 1 (5%) -
  Georgia - - 1 (5%) 14M (15%)
Germany 1 (6%) - 1 (5%) -
Austria 1 (6%) - 1 (5%) -
Belgium 1 (6%) - 1 (5%) -
Netherlands 1 (6%) - 1 (5%) -
Switzerland 1 (6%) - 1 (5%) -
Total 18 $79M 20 $92M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Buyout (LBO, MBO, MBI) 12 (67%) - 13 (65%) 14M (15%)
Growth Capital 2 (11%) - 3 (15%) -
Secondary Buyout 3 (17%) - 3 (15%) -
Going Private 1 (6%) 79M (100%) 1 (5%) 79M (85%)
Total 18 $79M 20 $92M

Exits by Deal Type

Type Total # Value
Secondary Sale 1 (100%) -
Total 1 -

Top M&A Advisors

Legal Deals
Gianni Origoni Grippo & Partners
 1

Deal Values

buy # Total
< $100M 2 $92M
TOTAL $92M
Largest Bomi Italia S.p.A.
$79M (2019-03-01)

M&A Connections

Deals
Acquired from
Investor(s)
15%
3 (15%)
Exited to
Investor(s)
100%
1 (100%)

Investor Summary

Investor Type

Private Equity Firm

Size

Middle-Market

Established

2014

Specialist/Generalist

Specialist

Leadership

Denis Ribon

Co-Founder & Partner

Brian Sheridan

Operating Partner

Christoph Bohmer

Operating Partner

Christophe Berthoux

Operating Partner

Jean Yves Desmottes

Operating Partner

 Subscribe to unlock this and 169,851
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.2K Private Equity Firms
  • 159K M&A Transactions
  • 166K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.3K M&A Advisors
    (Investment Banks and Law Firms)
  • 57K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal